NCT03886155
- Conditions
- Amyloidosis, Amyloidosis, Hereditary, Transthyretin-Related, Immune System Diseases, +18 more
- Locations
-
- Cleveland Clinic Cleveland, Ohio, United States
Clinical trial condition
Amyloidosis, Hereditary, Transthyretin-Related
Explore clinical trials studying Amyloidosis, Hereditary, Transthyretin-Related. Study availability and eligibility vary by location and protocol.
63 public trials
17 recruiting studies
Amyloidosis, Hereditary, Transthyretin-Related trial results
NCT01855360
- Conditions
- Alzheimer Disease, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +22 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
NCT03591757
- Conditions
- Amyloidosis, Amyloidosis, Hereditary, Transthyretin-Related, Amyloidosis, Leptomeningeal, Transthyretin-Related, +4 more
- Locations
-
- Amyloidosis Center, Boston Medical Center Boston, Massachusetts, United States
Completed
A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects
NCT02797847
- Conditions
- Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +14 more
- Locations
-
- Clinical Trial Site London, United Kingdom
NCT02319005
- Conditions
- Alzheimer Disease, Amyloid Neuropathies, Amyloid Neuropathies, Familial, +27 more
- Locations
-
- Clinical Trial Site Bakersfield, California, United States
- Clinical Trial Site Beverly Hills, California, United States
- Clinical Trial Site La Mesa, California, United States
- Clinical Trial Site Los Angeles, California, United States
NCT02016365
- Conditions
- Amyloidosis, Hereditary, Transthyretin-Related, Cardiomyopathies, Cardiomyopathy, +3 more
- Locations
-
- Dept of Clinical Medicin, Ptieå Hospital Piteå, Sweden
- Dept of clinical medicin, Skellefteå Hospital Skellefteå, Sweden
- Dept of Clinical Medicine, Umeå University Hospital Umeå, Sweden
NCT01171859
- Conditions
- Amyloidosis, Amyloidosis, Hereditary, Transthyretin-Related, Metabolic Diseases, +3 more
- Locations
-
- Amyloid Research and Treatment Centre, Biotechnology Research Laboratories Pavia, Italy
Active, Not Recruiting
Safety, Efficacy, and Pharmacokinetics of Tafamidis in Patients With Transthyretin-mediated Amyloidosis Post Orthotopic Heart Transplantation
NCT05489523
- Conditions
- Amyloidosis, Hereditary, Transthyretin-Related, Transthyretin Cardiac Amyloidosis
- Locations
-
- Cedars-Sinai Beverly Hills, California, United States
- Columbia University Medical Center New York, United States
- Cleveland Clinic Cleveland, Ohio, United States
- UT Southwestern Medical Center Dallas, Texas, United States
NCT06360289
- Conditions
- Amyloidosis, Hereditary, Transthyretin-Related, Asymptomatic Carrier State, Hereditary Amyloidosis, Transthyretin-Related
- Locations
-
- Centre Hospitalier Universitaire (CHU) Le Kremlin-Bicêtre Assistance Publique-Hôpitaux de Paris (APHP) Paris, Île-de-France Region, France
Active, Not Recruiting
HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT04153149
- Conditions
- Amyloidosis, Amyloidosis, Familial, Amyloidosis, Hereditary, Transthyretin-Related, +10 more
- Locations
-
- Clinical Trial Site La Mesa, California, United States
- Clinical Trial Site Los Angeles, California, United States
- Clinical Trial Site Stanford, California, United States
- Clinical Trial Site Washington D.C., District of Columbia, United States